Form 4: HealthEquity Director Natarajan Acquires Restricted Stock Units
SEC Form 4 Filing
Rajesh Natarajan, a director of HealthEquity, Inc., acquired 2,543 restricted stock units on July 5, 2024, convertible to common stock, vesting on July 5, 2025, or the next annual stockholder meeting.
Summary
- On July 5, 2024, Rajesh Natarajan, a director of HealthEquity, Inc., acquired 2,543 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of HealthEquity's common stock.
- The RSUs vest in full on the earlier of July 5, 2025, or the date of the issuer's next annual stockholder meeting.
- Upon vesting, the shares will be delivered to Mr. Natarajan.
- Following the transaction, Mr. Natarajan beneficially owns 11,503 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing an equity grant to a director, which is neither overtly positive nor negative.
Positives
- The acquisition of restricted stock units by a director signals confidence in the company's future performance.
Future Outlook
The restricted stock units vest on the earlier of July 5, 2025, or the date of the issuer's next annual stockholder meeting, indicating a future event that will result in the delivery of shares to the reporting person.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of restricted stock units, a common form of equity compensation.
Comparison to Industry Standards
- Equity compensation in the form of restricted stock units is a standard practice among publicly traded companies to align the interests of directors and management with those of shareholders.
- The vesting schedule of one year is fairly typical for RSU grants.
Stakeholder Impact
- The acquisition of restricted stock units by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/26/2023 | Date of Power of Attorney filing by Mr. Natarajan with the SEC. |
| 07/05/2024 | Date of transaction: Acquisition of 2,543 restricted stock units. |
| 07/05/2025 | Vesting date of the restricted stock units, or the date of the next annual stockholder meeting, whichever is earlier. |
| 07/09/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.